Skip to main content
Clinical Trials/ACTRN12617001490369
ACTRN12617001490369CompletedPhase 1

Palatable and chewable tramadol chocolate-based tablets for pain management in paediatric patients

Princess Margaret Hospital0 sites147 target enrollmentStarted: October 23, 2017Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
147

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
3 Years to 16 Years (—)
Sex
All

Inclusion Criteria

  • •Male or female, 3 to 16 years of age
  • •Treating anaesthetist considering patient suitable for pre-procedural tramadol
  • •Obtained informed parental or guardian consent and child assent where appropriate

Exclusion Criteria

  • •Known allergy to chocolate (chocolate base does not contain nuts)
  • •Known allergy/intolerance to tramadol or opioids
  • •Unable to understand the information sheet and the consent form
  • •Patient taking medication known to interact with tramadol (e.g. serotonergic agents, warfarin, ketoconazole)
  • •Known significant renal or hepatic impairment
  • •Known seizure disorder or epilepsy
  • •Participants undergoing surgeries that remove the tonsils or adenoids.
  • •Obese (as detailed by a BMI percentile above the 95th)
  • •Known severe obstructive sleep apnoea as documented by an overnight sleep study
  • •Known severe respiratory disease with significant impact on daily life

Investigators

Similar Trials